Abstract:Loss-of-function mutations in methyl-CpG binding protein 2 (MECP2) cause Rett syndrome, a postnatal neurodevelopmental disorder that occurs in ~1/10,000 live female births. MeCP2 binds to methylated cytosines across genomic DNA and recruits various partners to regulate gene expression. MeCP2 has been shown to repress transcription in vitro and interacts with co-repressors such as the Sin3A and NCoR complexes. Based on these observations, MeCP2 has been largely considered as a repressor of transcription. However, a mouse model of RTT displays many down-regulated genes, and those same genes are up-regulated in a MECP2 duplication mouse model. Furthermore, TCF20, which has been associated with transcriptional activation, have recently been identified as a protein interactor of MeCP2. These data broaden the potential functions of MeCP2 as a regulator of gene expression. Yet, the molecular mechanisms underlying MeCP2-dependent gene regulation remain largely unknown. Here, using a human MECP2 gain-of-function Drosophila model, we screened for genetic modifiers of MECP2-induced phenotypes. Our approach identified several subunits of the Drosophila super elongation complex, a P-TEFb containing RNA polymerase II (RNA pol II) elongation factor required for the release of promoter-proximally paused RNA pol II, as genetic interactors of MECP2. We discovered that MeCP2 physically interacts with the SEC in human cells and in the mouse brain. Furthermore, we found that MeCP2 directly binds AFF4, the scaffold of the SEC, via the transcriptional repression domain. Finally, loss of MeCP2 in the mouse cortex caused reduced binding of AFF4 specifically on a subset of genes involved in the regulation of synaptic function, which also displayed the strongest decrease in RNA pol II binding in the genebody. Taken together, our study reveals a previously unrecognized mechanism through which MeCP2 regulates transcription, providing a new dimension to its regulatory role in gene expression.

MeCP2 inhibits cell functionality through FoxO3a and autophagy in endothelial progenitor cells

MeCP2-mediated epigenetic regulation in senescent endothelial progenitor cells

Methyl-CpG-binding Protein 2 Drives the Furin/TGF-β1/Smad Axis to Promote Epithelial–mesenchymal Transition in Pancreatic Cancer Cells

MeCP2 Mediated Dysfunction in Senescent EPCs.

MeCP2 Promotes Endothelial-to-mesenchymal Transition in Human Endothelial Cells by Downregulating BMP7 Expression

MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells.

Transcriptional Inhibition of the Mecp2 Promoter by MeCP2E1 and MeCP2E2 Isoforms Suggests Negative Auto-Regulatory Feedback that can be Moderated by Metformin

MeCP2 Deficiency Promotes Cell Reprogramming by Stimulating IGF1/AKT/mTOR Signaling and Activating Ribosomal Protein-Mediated Cell Cycle Gene Translation.

Mecp2 Inhibits Proliferation And Migration Of Breast Cancer Via Suppression Of Epithelial-Mesenchymal Transition

MeCP2 Drives Hepatocellular Carcinoma Progression Via Enforcing HOXD3 Promoter Methylation and Expression Through the HB-EGF/EGFR Pathway.

MeCP2 triggers diabetic cardiomyopathy and cardiac fibroblast proliferation by inhibiting RASSF1A

Overexpression of methyl-CpG binding protein 2 impairs T(H)1 responses.

MECP2 Promotes Cell Proliferation by Activating ERK1/2 and Inhibiting P38 Activity in Human Hepatocellular Carcinoma HEPG2 Cells.

MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex.

METTL1 Limits Differentiation and Functioning of EPCs Derived from Human-Induced Pluripotent Stem Cells Through a MAPK/ERK Pathway

Autophagy in Endothelial Progenitor Cells is Cytoprotective in Hypoxic Conditions.

Autophagy Inhibits Endothelial Progenitor Cells Migration Via the Regulation of MMP2, MMP9 and Upa under Normoxia Condition

Role of Mir-132/Methyl-cpg-binding Protein 2 in the Regulation of Neural Stem Cell Differentiation

MeCP2 Interacts with the Super Elongation Complex to Regulate Transcription

MeCP2 Attenuates Cardiomyocyte Hypoxia/reperfusion-Induced Injury Via Regulation of the SFRP4/Wnt/β-catenin Axis

E2F1 Suppresses Oxidative Metabolism and Endothelial Differentiation of Bone Marrow Progenitor Cells.